What is the optimal management for keloid scars?

Keloid Scar Management

For keloid scars, intralesional corticosteroid injection (triamcinolone acetonide 10-40 mg/mL) is the first-line treatment, with surgical excision reserved for refractory cases and always combined with adjuvant therapy such as post-operative radiotherapy or immediate corticosteroid injection to prevent recurrence.

Primary Treatment Approach

First-Line: Intralesional Corticosteroids

Triamcinolone acetonide remains the gold standard initial therapy 1:

• Dosing: 10-40 mg/mL injected directly into the keloid
• Mechanism: Reduces inflammation and collagen synthesis
• Efficacy: Well-established over decades of use
• Repeat injections typically needed every 4-6 weeks

Emerging Superior Option: OnabotulinumtoxinA

Recent evidence suggests onabotulinumtoxinA is superior to both corticosteroids and 5-fluorouracil for treating keloids 2. This represents a paradigm shift, though availability and cost may limit widespread adoption.

Alternative Injectable: Intralesional Cryotherapy

Liquid nitrogen injected directly into the scar shows benefit, particularly effective when combined with corticosteroid injection 3, 2.

Prevention Strategies (Critical for High-Risk Patients)

Patients with personal or family history of keloids should avoid elective skin trauma including piercings, tattoos, and unnecessary procedures 4.

For unavoidable surgery in keloid-prone patients:

• Minimize wound tension using proper closure techniques
• Administer corticosteroid injections 10-14 days post-surgery (superior timing compared to intraoperative injection) 2
• Consider prophylactic silicone gel sheets or pressure therapy
• Reduce inflammatory response during healing

Surgical Management Algorithm

Surgery alone has extremely high recurrence rates and should NEVER be performed as monotherapy 5, 6.

When Surgery is Indicated:

1. Small, single keloids: Complete excision followed immediately by adjuvant therapy
2. Large, multiple keloids: Volume-reducing surgery (debulking) rather than complete excision

Mandatory Adjuvant Therapy Post-Excision:

Choose ONE of the following:

• Post-operative radiotherapy (12 Gy in 6 fractions using soft X-ray): 50% non-recurrence rate at 2 years 7
• Immediate intralesional corticosteroid injection into the surgical site
• Laser ablation of the wound edges

Critical caveat: Keloids with previous failed treatments have significantly higher recurrence rates (69.2% in pretreated cases) 7. This makes initial treatment selection crucial.

Non-Invasive Adjunctive Therapies

These should be used alongside, not instead of, primary treatments:

• Silicone gel sheets: Apply continuously for months; reduces tension and inflammation
• Pressure therapy: Particularly useful for ear and trunk keloids
• Topical corticosteroid ointments: Reduce inflammation in early/active keloids

Advanced/Refractory Cases

Combination Therapy Approach:

For keloids failing initial treatment 5, 8:

1. Cryotherapy (liquid nitrogen application)
2. Immediately followed by intralesional corticosteroid injection
3. Consider adding 5-fluorouracil (intralesional) to the corticosteroid

Novel Agents (Limited Evidence):

• Dupilumab: Variable results; may worsen some keloids by promoting Th17 differentiation 9. Grade D recommendation - insufficient evidence to recommend routinely
• Laser therapy: Pulsed dye laser or fractional CO2 for laser-assisted drug delivery 2
• Radiation therapy alone: Reserved for recurrent keloids; contraindicated in children 9

Location-Specific Considerations

Ear keloids: Higher metastatic potential if progression to SCC occurs; aggressive treatment warranted 10

Trunk keloids: Most common location (49%); respond well to pressure therapy combined with injections 7

Avoid treatment near: Eyelids, lips, nose (risk of functional impairment)

Critical Pitfalls to Avoid

1. Never perform keloid excision without planned adjuvant therapy - recurrence is nearly guaranteed
2. Avoid radiation in children - use alternative adjuvants like corticosteroids 9
3. Do not inject excessive corticosteroid volumes - causes atrophy, pigmentary changes, and telangiectasias 1
4. Pretreated keloids have worse outcomes - get initial treatment right the first time 7
5. Black henna temporary tattoos should be avoided in keloid-prone individuals due to sensitization risk 4

Monitoring and Follow-Up

• Long-term follow-up mandatory: Keloids can recur years after apparent successful treatment 5
• Assess for recurrence at 3,6,12, and 24 months minimum
• Earlier intervention for recurrence yields better outcomes than waiting for full regrowth